SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000930413-20-000595
Filing Date
2020-02-27
Accepted
2020-02-27 16:53:11
Documents
1
Period of Report
2020-02-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 4901
  Complete submission text file 0000930413-20-000595.txt   6233
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Issuer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
SIC: 8071 Services-Medical Laboratories

Mailing Address ENZO BIOCHEM, INC. 527 MADISON AVENUE NEW YORK NY 10022
Business Address
Bench David (Reporting) CIK: 0001797876 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-09974 | Film No.: 20663204